Recent Updates
Recently added Catalysts
LFWD Positive Sentiment Score: 70/100

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Key Takeaway: Lifeward Ltd. announced that it will report its fourth quarter and full year 2025 financial results on March 18, 2026. Company executives will host a conference call to discuss these results, which can be accessed by analysts and investors via multiple channels. Lifeward is recognized for its innovative medical technologies that aim to improve the lives of individuals with physical limitations. The company’s commitment to innovation is highlighted through their range of products designed for rehabilitation.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of upcoming financial results indicates transparency.
  • Lifeward is described as a leader in innovative medical technology.
  • The company is committed to delivering groundbreaking solutions.

Full Press Release Details

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and full year 2025 financial results before the markets open on Wednesday, March 18, 2026.
Mark Grant, President and Chief Executive Officer, and Almog Adar, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following:
Toll free (U.S.) 1-833-316-0561
International (U.S) 1-412-317-0690
Germany 0800-6647650
Israel 1-80-9212373
Access Code Please reference the “Lifeward Earnings Call”
The conference call will be webcast live and can be accessed through a link on the Company’s website at golifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/yc9qmwr7. An archived webcast will also be available on the Company's website at the Investor Events Calendar page.
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Chief Financial Officer

Frequently Asked Questions

When will Lifeward release its 2025 financial results?

Lifeward will announce its fourth quarter and full year 2025 financial results on March 18, 2026.

Who will host the Lifeward earnings call?

Mark Grant, President and CEO, and Almog Adar, CFO, will host the earnings call.

How can I access the Lifeward earnings call?

The Lifeward earnings call can be accessed via phone or the Company's website.

What is the focus of Lifeward's products?

Lifeward's products aim to enhance physical rehabilitation and recovery for individuals.

When was Lifeward founded?

Lifeward was founded in 2001 and operates in the U.S., Israel, and Germany.

Last updated: Mar 10, 2026